Publicité
Publicité
ATHA
Athira Pharma, Inc. Common Stock
6.75
USDSponsorisé
-0.44
-6.12%
09 janv., 15:59 UTC -5
Fermé
Après-marché
6.89
+0.14
+2.07%
ATHA Rapports sur les bénéfices
Ratio de surprise positive
ATHA a dépassé 15 des 21 dernières estimations.
71%
Prochain rapport
Date du prochain rapport
25 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.87
Variation implicite de Q3 25 (Revenue/ EPS)
--
/-48.21%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-77.69%
Athira Pharma, Inc. Common Stock earnings per share and revenue
On 06 nov. 2025, ATHA reported earnings of -1.68 USD per share (EPS) for Q3 25, missing the estimate of -1.24 USD, resulting in a -35.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.99% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of -0.87 USD, with revenue projected to reach -- USD, implying an baisse of -48.21% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
What were Athira Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Athira Pharma, Inc. Common Stock reported EPS of -$1.68, missing estimates by -35%, and revenue of $0.00, 0% as expectations.
How did the market react to Athira Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.99%, changed from $4.01 before the earnings release to $3.85 the day after.
When is Athira Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 févr. 2026.
What are the forecasts for Athira Pharma, Inc. Common Stock's next earnings report?
Based on 4
analystes, Athira Pharma, Inc. Common Stock is expected to report EPS of -$0.87 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité